Nitric oxide-modulating agents for gastrointestinal disorders
about
Pharmacologic profile and therapeutic potential of NCX 4016, a nitric oxide-releasing aspirin, for cardiovascular disordersMicrobiome and potential targets for chemoprevention of esophageal adenocarcinoma.Molecular pathways: pathogenesis and clinical implications of microbiome alteration in esophagitis and Barrett esophagusCelecoxib-induced gastrointestinal, liver and brain lesions in rats, counteraction by BPC 157 or L-arginine, aggravation by L-NAMEThe four-herb Chinese medicine PHY906 reduces chemotherapy-induced gastrointestinal toxicity.
P2860
Nitric oxide-modulating agents for gastrointestinal disorders
description
2005 nî lūn-bûn
@nan
2005 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Nitric oxide-modulating agents for gastrointestinal disorders
@ast
Nitric oxide-modulating agents for gastrointestinal disorders
@en
Nitric oxide-modulating agents for gastrointestinal disorders
@nl
type
label
Nitric oxide-modulating agents for gastrointestinal disorders
@ast
Nitric oxide-modulating agents for gastrointestinal disorders
@en
Nitric oxide-modulating agents for gastrointestinal disorders
@nl
prefLabel
Nitric oxide-modulating agents for gastrointestinal disorders
@ast
Nitric oxide-modulating agents for gastrointestinal disorders
@en
Nitric oxide-modulating agents for gastrointestinal disorders
@nl
P2860
P1476
Nitric oxide-modulating agents for gastrointestinal disorders
@en
P2093
Brendan J R Whittle
P2860
P304
P356
10.1517/13543784.14.11.1347
P407
P577
2005-11-01T00:00:00Z